Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Active, not recruitingOBSERVATIONAL

Enrollment

135

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2026

Conditions

EndometriosisEndometrial Diseases

Trial Locations (3)

Johns Hopkins Hospital, Baltimore

Vanderbilt University Medical Center, Nashville

Yale School of Medicine, New Haven

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Johns Hopkins University

OTHER